Yahoo! Finance Search - Finance Home - Yahoo! - Help

Tuesday, September 2 2014 5:55pm ET - U.S. Markets Closed.
Industry Center - Drug Manufacturers - Other
Industry Center > Drug Manufacturers - Other > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Drug Manufacturers - Other News
Latest News
Tuesday, Sep 2, 2014
·Kirby McInerney LLP Announces That a Class Action Has Been Filed on Behalf of Lannett Company, Inc. Investors
Business Wire - 1 hour, 55 minutes ago
·Depomed Announces Offering of $230 Million Convertible Senior Notes Due 2021
PR Newswire - 1 hour, 55 minutes ago
·UCB's Epilepsy Drug Vimpat's Label Expanded in the U.S. - 2 hours, 9 minutes ago
·Glaxo Up on Accelerated Ebola Vaccine Development Process - Tue 2:40 pm ET
·Why Endo International Can Deliver Solid Rewards With Minimal Risk
at - Tue 2:31 pm ET
·[$$] Novo's Comeback Hinges on Regulators
at The Wall Street Journal Online - Tue 2:30 pm ET
·Novo Nordisk's Ryzodeg Now in Mexico for Type II Diabetes - Tue 2:00 pm ET
·U.S. court revives Botox-linked shareholder suit against Allergan
Reuters - Tue 1:33 pm ET
·U.S. court revives shareholder lawsuit vs. Allergan over Botox
Reuters - Tue 12:06 pm ET
·SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against Lannett Company, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of October 27, 2014 -- LCI
GlobeNewswire - Tue 10:52 am ET
·Allergan Files Answer in Federal Court Responding to Valeant and Pershing Square’s Counterclaims
Business Wire - Tue 9:01 am ET
·MEI Pharma Completes Enrollment In Randomized Phase II Clinical Trial Of Pracinostat In Front Line Myelodysplastic Syndrome
PR Newswire - Tue 8:30 am ET
·Teva’s Reslizumab Delivers Clinically and Statistically Significant Reduction in Asthma Exacerbations in Two Pivotal Phase III Studies
Business Wire - Tue 8:01 am ET
·Orexigen Expands NB32 Intellectual Property Portfolio With New U.S. Patent
PR Newswire - Tue 8:00 am ET
·Allergan Announces OZURDEX® (dexamethasone 700 mcg intravitreal implant in applicator) Now Approved in the European Union for the Treatment of Diabetic Macular Edema
Business Wire - Tue 8:00 am ET
·United Therapeutics (UTHR) Shares March Higher, Can It Continue? - Tue 7:58 am ET
·Drugs from Isis' Lipid Franchise Highlighted at European Society of Cardiology Congress 2014
PR Newswire - Tue 7:00 am ET
Monday, Sep 1, 2014
·Hershkovitz to Leave Post at Israeli Hedge Fund Sphera
at Bloomberg - Mon 11:04 am ET
·SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Lannett Company to Contact Brower Piven Before the October 27, 2014 Lead Plaintiff Deadline in Class Action Lawsuit -- LCI
GlobeNewswire - Mon 10:43 am ET
Saturday, Aug 30, 2014
·Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Lannett Company, Inc. (LCI) to Contact the Firm
Marketwire - Sat Aug 30
More Latest News...
Sponsor Results
Corporate Compliance
Issues? Let GFI EventsManager help your compliance. Download trial!
Buying Physical Gold
Info on Prices & Tips for Investors Request a Free Investor Kit Now!
GMP + cGMP Oligos
Reliable. Reputable. Replicable. In-vitro oligos for IVD & ASR
(What's This?)

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Manufacturers - Other Headlines
More Finance RSS Feeds

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?